does anthem cover glp-1 for weight loss Wegovy or Zepbound? Virginia 2026 Guide Is this a hard no?

Individuals with a history of eating disorders, depression, anxiety, trauma, or substance use concerns are encouraged to consult both medical and mental health professionals when considering GLP-1 treatment

According to FDA prescribing information, gallbladder-related adverse events occurred in clinical trials of semaglutide for weight management (Wegovy) at rates of 2.5% versus 1.0% with placebo, and for tirzepatide (Zepbound) at rates of 2.5% versus 1.0% with placebo

doi: 10.1016/j.jaut.2019.06.012 117 ToughDFBorrowPSprentJ

Average weight loss is 15% of body weight in 12 months

Shin, J.S

51, 52, 53 Consistent with findings from heterologous cell lines and striatal synaptosomes, 51, 52, 53 we first demonstrated that AA application to LS slices significantly reduced DA uptake (Figure 3c)